Table Of Content

INTERNATIONAL JOURNAL OF Antimicrobial Agents International Journal of Antimicrobial Agents 4 (1994) 340-343 Contents Volume 4 No. 1 Viral infections of the respiratory tract: prevention and treatment J.J. Treanor | Cefuroxime axetil P. Dellamonica 23 Cefpodoxime proxetil: a comprehensive review W.M. Todd 37 Pneumococcal resistance to the third-generation cephalosporins: clinical, laboratory and molecular aspects K.P. Klugman 63 Development of amikacin resistance in bacterial isolates in Slovakia (1990-1992) P. MiloSovicé, T. Maciékova, M. Kettner and J. Kallova 69 Current issues on the prophylaxis and the management of fungal infections in leukemic patients FEF. Meunier 73 Calendar 77 Instructions to Authors 79 No. 2 Special Issue: Urinary Tract Infections Introduction I.M. Hoepelman 81 The management of urinary infections: what have we learned in the past decade? G.K.M. Harding and A.R. Ronald 83 The mucosal cytokine response to urinary tract infections S. Hedges and C. Svanborg 89 Management of uncomplicated urinary tract infections R.R. Bailey 95 Host defense mechanism in the pathogenesis of UTI and UTI in immunocompromised patients O.M. Korzeniowski 101 0924-8579/94/$26.00 © 1994 Elsevier Science B.V. All rights reserved Contents Volume 4/ International Journal of Antimicrobial Agents 4 (1994) 340-343 341 Consequences of asymptomatic bacteriuria in the elderly L.E. Nicolle 107 Urinary tract infection in patients with diabetes mellitus I.M. Hoepelman 113 Catheter-associated urinary tract infections: epidemiological, preventive and therapeutic considerations W.N.M. Hustinx and H.A. Verbrugh 117 Complicated urinary tract infections R. Gleckman 125 Useful agents in the management of urinary tract infections S.R. Norrby 129 Management of candiduria B.J. Guglielmo, M.L. Stoller and R.A. Jacobs 135 No. 3 Editorial Worldwide resistance against antibiotics J. Verhoef 14] Resistance to antimicrobial agents of common bacteria isolated from Taiwan S.-C. Chang, W.-C. Hsieh and K.-T, Luh 143 Activity of eight fluoroquinolones against methicillin-resistant Staphylococcus aureus isolated from cutaneous infections S. Nishijima, S. Namura, H. Akamatsu, Y. Asada, S. Kawabata and M. Fujita 147 The concentration of sparfloxacin in lung tissues after single and multiple oral doses D. Honeybourne, I. Greaves, D.R. Baldwin, J.M. Andrews, M. Harris and R. Wise 151 Treatment and developmental therapeutics of Mycobacterium tuberculosis infections V.S. Georgiev 157 In vitro and in vivo activities of clarithromycin against the Mycobacterium avium complex H. Saito, H. Tomioka, K. Sato and S. Dekio 175 Macrolide transport in Escherichia coli strains having normal and altered OmpC and/or OmpF porins J.O. Capobianco and R.C. Goldman 183 Antibiotics enhance binding of lipid A-specific murine monoclonal antibody E5 to Gram-negative bacteria A.S. Bouter, K.P.M. van Kessel, J.J. Cornelissen, J.F P. Schellekens, Y.Y. van der Hoek, H. Snippe and J. Verhoef 19] Pefloxacin single-dose in the treatment of acute uncomplicated lower urinary tract infections in women: a meta-analysis of seven clinical trials 197 K.G. Naber, W. Baurecht, M. Fischer and M. Kresken 342 Contents Volume 4/International Journal of Antimicrobial Agents 4 (1994) 340-343 Clinical efficacy and safety of cefetamet pivoxil in toddlers A. Chibante, E. Peixoto, R. Lejeune, K. Winter and M. Kissling 203 Chemotherapy of varicella zoster virus infections R. Snoeck, G. Andrei and E. De Clercq 211 Drugs used in the treatment of sleeping sickness (human African trypanosomiasis: HAT) M. Wery 227 Calendar 239 240 Announcement No. 4 Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients H. Degreef and Famciclovir Herpes Zoster Clinical Study Group 241 Treatment and developmental therapeutics of Mycobacterium avium complex (MAC) infections V.S. Georgiev 247 Development of an in vitro drug screening system for Mycobacterium leprae based on the determination of the intrabacterial sodium to potassium ratio of individual bacterial organisms M. Wiese, B. Lindner and U. Seydel 271 Activities of liposome-encapsulated azithromycin and rifabutin compared with that of clarithromycin against Mycobacterium avium-intracellulare complex in human macrophages C.O. Onyeji, C.H. Nightingale, D.P. Nicolau and R. Quintiliani 281 The BCG controversy J. Verhoef 291 Invasive group A streptococcal infection: new concepts in antibiotic treatment D.L. Stevens, A.E. Bryant and S. Yan 297 Antifungal activity of a new benzothiazole derivative against Candida in vitro and in vivo H. Bujdakova and M. Miuckova 303 Leishmaniasis and itraconazole: a controlled clinical trial on cutaneous subtypes J. Dogra and N. Aneja 309 Use of praziquantel against schistosomiasis: a review of current status V. Kumar and B. Gryseels 313 The efficacy of praziquantel for the treatment of cestode and metacestode infections S. Geerts 321 Minocycline: old and new therapeutic uses C.D. Freeman, C.H. Nightingale and R. Quintiliani 325 Contents Volume 4/International Journal of Antimicrobial Agents 4 (1994) 340-343 343 Author Index 337 Contents Volume 4 340 Supplement 1 A critical review of the dosage of teicoplanin in Europe and the USA A.P.R. Wilson, R.N. Griineberg and H. Neu S1 Supplement 2: Profile of fleroxacin, a new once daily quinolone Fleroxacin: the newly introduced once-daily quinolone VT. Andriole Sl Implications of fleroxacin’s pharmacokinetic profile C.H. Nightingale S7 Tissue pharmacokinetics of fleroxacin in humans as determined by positron emission tomography R.H. Rubin, E. Livni, J. Babich, N.M. Alpert, Y.-Y. Liu, R. Cleeland, B.L.T. Prosser, E. Thom and A.J. Fischman S15 Comparative evaluation of fleroxacin, ampicillin, trimethoprim-sulfamethoxazole, and gentamicin as treatments of catheter-associated urinary tract infection in a rabbit model D.W. Morck, K. Lam, S.G. McKay, M.E. Olson, B. Prosser, B.D. Ellis, R. Cleeland and J.W. Costerton S21 Quinolones in the treatment of complicated urinary tract infection W. Graninger, C. Wenisch and E. Presterl S29 Uncomplicated urinary tract infections — is single-dose therapy effective? K.G. Naber S39 Use of fluoroquinolones in lower respiratory tract infections (LRTI) H. Lode, T. Schaberg, G. Hoffken and K. Borner S47 Opportunities for i.v. to oral switch in the management of infections: the role of quinolones D. Lew $53 Conclusion V.T. Andriole and D. Lew S59